|
Vaniqa is a new FDA approved prescription medication applied
to the skin for the reduction of unwanted facial hair.
Vaniqa is prescribed for the treatment of unwanted facial
hair around the lips and under the chin. The fragrance-free medication
is applied similar to a moisturizing cream twice a day. Vaniqa
works by actively inhibiting an enzyme locate in the root of the
hair follicle, which is responsible for hair growth. The medical
breakthrough, Vaniqa, is proven to stop and prevent the growth
of unwanted facial hair. Finally there is a solution for the estimated
one in six women who suffer from unwanted facial hair.
Many women consider the problem serious enough to warrant bleaching,
tweezing, hot wax, electrolysis and even shaving. Vaniqa
now represents a better treatment option than these traditional
hair removal options:
As a physician, I am excited about the potential
for this new prescription cream to help women manage unwanted facial
hair,” said Marty E. Sawaya, M.D., Ph.D, adjunct professor, department
of biochemistry and molecular biology, University of Miami, and
a dematologist and clinical research investigator at ARATEC Clinics
in Ocala, Florida. “Importantly, Vaniqa will potentially help millions
of woman with this condition to feel less bothered by their facial
and the amount of time they spend removing, treat, or concealing
the excessive growth.”
Vaniqa (eflornithine hydrochloride) Cream, 13.9% was developed
through a unique partnership between The Gillette Company and the
well-respected pharmaceutical company Bristol-Myers Squibb. The
companies formed a unique partnership in 1996 in order to complete
development of the hair removal medication. Individuals can now
order the FDA approved Vaniqa online via an online consultation.
|
